Replengen Fine

Replengen Fine: Ultra-Low G’ Monophasic HA Filler for Superficial Lines, Hydration & Subtle Refinement

Replengen Fine, manufactured by **Hugel Inc.** (South Korea), is an **ultra-low viscosity, low G-prime (G’) monophasic hyaluronic acid (HA) dermal filler** specifically formulated for the **superficial dermis**. Presented in a **1.0 ml prefilled syringe**, it contains a **high concentration of cross-linked HA (24 mg/ml)** and features **integrated 0.3% lidocaine HCl** for enhanced comfort. Designed for delicate correction, Replengen Fine excels at addressing fine lines, improving skin quality, and providing subtle hydration with minimal tissue displacement.https://skin-reboot.com/

**Core Technology & Properties:**
* **Ultra-Low G-Prime Monophasic NASHA Gel:** Features a uniform, highly homogeneous HA matrix (Crystal Matrix Technology™) with **exceptionally low elasticity (low G’) and viscosity**. This provides minimal lifting force, ensuring soft integration and natural-looking correction in the delicate upper dermis without over-projection or visibility.
* **High Cohesivity:** Particles bind cohesively, minimizing migration risk while allowing for smooth, even distribution in the superficial plane.
* **Integrated Anesthetic:** **0.3% lidocaine HCl** is uniformly dispersed within the gel, reducing injection discomfort.
* **Fine Particle Size & Fluidity:** Optimized for effortless injection through very fine needles and seamless spreading within the superficial dermis. Ideal for micro-droplet technique.
* **High Water-Binding Capacity:** Excellent hydrating properties due to HA’s hydrophilic nature.

**Mechanism of Action:**
1. **Superficial Line Correction:** Fills very fine wrinkles (e.g., crow’s feet, perioral lines, forehead lines) by integrating directly into the upper dermis.
2. **Skin Hydration & Radiance:** Binds significant amounts of water, improving skin moisture, elasticity, and luminosity (“glass skin” effect).
3. **Subtle Smoothing & Refinement:** Softens texture irregularities and provides a subtle, overall rejuvenated appearance without adding volume.
4. **Biostimulation:** Provides a scaffold for potential collagen stimulation over time.

**Primary Indications:**
* **Fine Periorbital Lines (Crow’s Feet):** Primary indication for delicate wrinkle effacement.
* **Perioral Lines (Smoker’s Lines, Lipstick Lines):** Smoothing vertical lip lines.
* **Superficial Forehead Lines:** Correcting very fine horizontal lines.
* **Décolletage & Neck Lines:** Improving fine horizontal neck lines and chest wrinkles/skin quality.
* **Overall Skin Quality Enhancement:** Boosting hydration, smoothness, and radiance via full-face micro-droplet technique.
* **Subtle Lip Texture Refinement:** Smoothing lip surface (not for volume/border definition).

**Key Administration Considerations:**
* **Ready-to-Use:** No reconstitution required. **Integrated 0.3% lidocaine.**
* **Anesthesia:** Integrated lidocaine provides significant pain relief. Topical anesthesia often sufficient adjunct.
* **Technique:**
* **Needles:** **Requires very fine needles (30-33G)** for precise superficial placement. **Aspiration generally not feasible/practical.**
* **Cannulas:** Less commonly used due to product fluidity and superficial target.
* **Methods:** **Micro-droplet technique** (multiple tiny, superficial blebs) is paramount for skin quality/radiance. **Intradermal micro-deposits** or **linear threading (very superficial)** for fine lines.
* **Depth:** **Critical: Papillary/Superficial Reticular Dermis.** Must remain extremely superficial (intradermal). Injection into mid-dermis risks visibility or Tyndall; deeper injection is ineffective/wasted.
* **Volume:** Low volumes per session. Multiple micro-droplets or threads with minimal product.
* **Post-Treatment:** Mild redness, pinpoint bleeding, transient swelling common. Bruising possible. Avoid massage/rubbing.
* **Longevity:** Typically **6-9 months**, varying with indication and technique (shorter for pure hydration/radiance).
* **Safety:**
* **Critical Risks:** **Tyndall Effect** (blue-gray discoloration – **most common risk** if injected too deep in dermis). **Visible Beading/Lumps** (if droplets too large or technique poor). **Vascular Compromise** (less common than with deep fillers, but possible in periorbital/labial areas – extreme caution near angular/retinal arteries).
* **Regulatory Status:** **CE marked** (Europe/international). **Not FDA-approved in the USA.**
* **Prescription:** Prescription medical device.

Replengen Fine demands meticulous technique for superficial placement, offering injectors a specialized tool for subtle rejuvenation, fine line correction, and skin quality enhancement with minimal downtime. Its ultra-low G’ nature prioritizes natural integration over volume.CONTACT US